Literature DB >> 16275156

Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.

Jose V Bagan, Yolanda Jimenez, Judith Murillo, Sergio Hernandez, Rafael Poveda, José M Sanchis, José M Diaz, Crispian Scully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16275156     DOI： 10.1016/j.oraloncology.2005.08.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  37 in total

Review 1.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

2.  Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw.

Authors:  M S Najm; D H Solomon; S-B Woo; N S Treister
Journal:  Oral Dis       Date:  2013-02-19       Impact factor: 3.511

Review 3.  Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report.

Authors:  Yusuf Farouk Suleman; Shabnum Meer; Russel Lurie
Journal:  Head Neck Pathol       Date:  2007-12-08

Review 4.  [Bisphosphonate-associated osteonecrosis of the jaw].

Authors:  Maria-Theresa Krauth; Alexander Fügl; Reinhard Gruber
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

5.  A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis.

Authors:  Ma Scheper; R Chaisuparat; Kj Cullen; Tf Meiller
Journal:  Fibrogenesis Tissue Repair       Date:  2010-04-01

Review 6.  Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.

Authors:  Benjamin A Gartrell; Robert E Coleman; Karim Fizazi; Kurt Miller; Fred Saad; Cora N Sternberg; Matthew D Galsky
Journal:  Eur Urol       Date:  2013-05-13       Impact factor: 20.096

7.  Osteonecrosis caused by Bisphosphonates: a clinical case.

Authors:  D Spinelli; G DE Vico; M Bonino; A Barlattani; P Bollero; A Barlattani
Journal:  Oral Implantol (Rome)       Date:  2010-05-25

8.  Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.

Authors:  Susi Zara; Marianna De Colli; Viviana di Giacomo; Vincenzo Luca Zizzari; Chiara Di Nisio; Umberto Di Tore; Vincenzo Salini; Marialucia Gallorini; Stefano Tetè; Amelia Cataldi
Journal:  Clin Oral Investig       Date:  2014-07-24       Impact factor: 3.573

9.  A novel bioassay model to determine clinically significant bisphosphonate levels.

Authors:  Mark A Scheper; Ashraf Badros; Andrew R Salama; Gary Warburton; Kevin J Cullen; Dianna S Weikel; Timothy F Meiller
Journal:  Support Care Cancer       Date:  2009-08-04       Impact factor: 3.603

Review 10.  Osteonecrosis of the jaws and bisphosphonates.

Authors:  David G Pendrys; Stuart L Silverman
Journal:  Curr Osteoporos Rep       Date:  2008-03       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.